Skip to content

Salesforce CRM Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Other financials

Income statement

See full
Revenue$11.1B+13.3%
Gross profit$8.6B+13.2%
Operating income$2.3B+20.9%
Net income$2.1B+36.7%
EPS (diluted)$2.42+52.2%

Balance sheet

See full
Cash & equivalents$8.9B-18.2%
Total debt$42.5B+254%
Total equity$34.2B-43.6%
Total assets$106.68B+8.2%

Cash flow

See full
Operating cash flow$6.7B+3.5%
CapEx$145.0M-19.0%
Free cash flow$6.6B+4.1%

Valuation

See full
Market cap$123.01B-50.6%
Enterprise value$156.62B-37.4%
P/E15.3×-24.8×
P/S2.9×-3.6×

Profitability

See full
Gross margin77.6%+0.3pp
Operating margin20.4%+1.1pp
Net margin18.7%+2.7pp
FCF margin34.2%+1.5pp

Returns & leverage

See full
Return on equity16.9%+6.6pp
Debt / equity1.2×+1.0×
Current ratio0.8×-0.3×